[FATE] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
16-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 9.12%
YoY- -6.63%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 1,026 1,026 1,027 1,027 1,026 1,027 1,322 -15.53%
PBT -10,684 -9,645 -10,126 -7,940 -8,737 -8,408 -8,377 17.58%
Tax 378 137 111 -160 37 31 27 479.94%
NP -10,684 -9,645 -10,126 -7,940 -8,737 -8,408 -8,377 17.58%
Tax Rate - - - - - - - -
Total Cost 11,710 10,671 11,153 8,967 9,763 9,435 9,699 13.37%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin -1,041.33 -940.06 -985.98 -773.13 -851.56 -818.70 -633.66 39.21%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -0.26 -0.23 -0.24 -0.21 -0.27 -0.29 -0.29 -7.01%
EPS Diluted -0.26 -0.23 -0.24 -0.21 -0.27 -0.29 -0.29 -7.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.